Polio Survivors & Associates, A Rotarian Action Group Dedicated to the humanitarian assistance of polio survivors.

In The News

 

The Rotarian Action Group for Polio Survivors and Associates is the living legacy of the Rotary Polio-Plus polio eradication program through humanitarian assistance to polio survivors of the world. This Action Group operates in accordance with Rotary International policy, but is not controlled by Rotary.

Check These Links!

 

2008 LA Convention

 

No Jabs? The Toronto Sun recently ran an article about parents who are opting not to immunize their children and the dangers of this choice.

Rotary's one small step for Somchai Click here to read the inspiring story of a young boy's journey of over 2000 miles for corrective surgery that will greatly change his life.

Education opens minds, and sometimes helps conquer peaks too. For Chauthi, crippled with polio as a child, married at 16 and disowned by her in-laws soon after, education has given a new focus to her life and made her self-reliant. Read Chauthi's amazing story here.

Oral histories are being recorded for a Warm Springs Center project. Click here to read the informative article in the Columbus Ledger-Enquirer.

Read the inspirational story of the little town of Hickory, North Carolina.

New Vaccine to Prevent Type-1 Polio Three Times as Effective as Standard Vaccine

Global Polio Eradication May Take Time

Wiping Out Polio Cheaper Than Giving Up: Study

New Analysis Says Eradicating Polio A Better Option Than Extended Control Of The Disease

US Saved 135 000 Lives $810 Billion - Polio Vaccines

 

New Vaccine To Prevent Type-1 PolioThree Times As Effective As Standard Vaccine

Disease/Infection News   Published:  Thursday, 12-Apr-2007

 The new vaccine to prevent type-1 polio is almost three times as effective as the standard vaccine, according to new research published in The Lancet.

The study found that each dose of the new monovalent oral poliovirus vaccine, known as mOPV1, protected 30% of susceptible children in northern India against paralytic poliomyelitis. The standard trivalent vaccine in the same setting protected just 11% of children per dose.

This is the first published study to confirm the success of mOPV1, a high potency vaccine developed, licensed and introduced to immunisation rounds to combat type 1 polio in India in 2005.

mOPV1 targets type 1 polio, the most prevalent of the three strains of the disease, compared with the trivalent vaccine, which targets types 1, 2 and 3. The efficacy of trivalent vaccines can be diminished because different strains of poliovirus interfere with one another inside the body, sometimes producing immunity to one strain but not another.

Monovalent vaccines do not incur problems with interference between vaccine strains because they include just one of the three strains.

Polio persists in northern India because of poor sanitation and crowded conditions which favour the spread of polio and can also reduce the efficacy of oral poliovirus vaccines. Children in the area often have diarrhoea or other infections that stop the vaccine from working properly.

The researchers found that by the end of 2006 in the states of Uttar Pradesh in India, between 76% and 82% of children aged 0-23 months were estimated to be protected by vaccination against type 1 polio, compared with 59% at the end of 2004, before the introduction of mOPV1.

 Dr Nick Grassly, lead author of today's study from the department of Infectious Disease Epidemiology at Imperial College London, said: "Our research shows that the clinical efficacy of the monovalent vaccine in this difficult setting is about three times that of the trivalent vaccine against type 1. This is important, since a child has an 80% chance of protection after 5 doses of this new vaccine. With the trivalent vaccine 14 doses were needed to reach this level of protection.

"The global eradication of type 2 wild poliovirus in 1999, probably due to the greater efficacy of the trivalent vaccine against this type, proves the concept that with a more efficacious vaccine, wild poliovirus can be eradicated," he added.

Today's study shows that providing multiple doses of mOPV1 to children in areas of endemic polio substantially improves the probability of rapidly eliminating the remaining chains of type 1 poliovirus transmission across the world. mOPV1 is a central element of the strategy for interrupting poliovirus transmission.

The researchers reached their conclusions after comparing the vaccination histories of 2076 children with paralytic type 1 polio with the same number of children with paralysis due to causes other than polio, who had a similar date of onset of paralysis, age and district of residence.

Polio is a highly infectious disease that primarily affects children under three years of age. Paralysis develops in a small minority of cases, which is permanent and can be fatal. The Global Polio Eradication Initiative, which started in 1988 and is spearheaded by the World Health Organization (WHO), Rotary International, the US Centers for Disease Control and Prevention (CDC) and UNICEF, has seen endemic polio eradicated everywhere except in parts of India, Pakistan, Afghanistan and Nigeria. Vaccination is a key part of this initiative. When the initiative began it was estimated that polio was paralysing 1,000 children every day, whereas in 2006 this number was approximately five children a day.

This study was supported by a Royal Society Research Fellowship to Dr Grassly.

The PSA excursion to the Rotary 99th International Convention, June 12-18 has been pronounced a success by almost any measure.

In this photo, Chair Ann Lee Hussey is shown with Gaston Kaba, PolioPlus Chairman of Niger as well as Peace Corp Co-ordinator.

World Health Organization (WHO) Director Margaret Chan is seen in the photos below with Ann Lee Hussey and Ray Taylor.


Rotary International
and Gates Foundation
Together Commit $200 Million
to Eradicate Polio

CONTACT: Vivian Fiore (847) 866-3234 or vivian.fiore@rotary.org

EVANSTON, Ill., U.S.A. (Nov. 26, 2007) Rotary International today announced a partnership with the Bill & Melinda Gates Foundation that will inject a much-needed US$200 million into the global campaign to eradicate polio, a crippling and sometimes fatal disease that still paralyzes children in parts of Africa, Asia and the Middle East and threatens children everywhere.

The Rotary Foundation has received a $100-million Gates Foundation grant, which Rotary will raise funds to match, dollar-for-dollar, over three years. The Evanston-based volunteer service organization will spend the initial $100 million within one year in direct support of immunization activities carried out by the Global Polio Eradication Initiative (GPEI), a partnership spearheaded by the World Health Organization (WHO), Rotary International, the U.S. Centers for Disease Control and Prevention and UNICEF.

"The extraordinary dedication of Rotary members has played a critical role in bringing polio to the brink of eradication," says Bill Gates, co-chair of the Bill & Melinda Gates Foundation. "Eradicating polio will be one of the most significant public health accomplishments in history, and we are committed to helping reach that goal."

The polio eradication grant is one of the largest challenge grants ever given by the Gates Foundation and the largest grant received by Rotary in its 102-year history. Polio eradication has been Rotary’s top priority since 1985. Since then, Rotary has contributed $633 million to the eradication effort.

"Rotary members worldwide have worked very hard over the years to reach this point, and it is rewarding to see our approach validated in such a significant way by the Bill & Melinda Gates Foundation," says Dr. Robert Scott, who leads Rotary’s polio eradication effort and chairs The Rotary Foundation, the not-for-profit charitable arm of Rotary that will administer the grant. "We hope that this shared commitment of Rotary and the Gates Foundation will challenge other donors – including foundations, governments and non-governmental organizations – to step up and make sure we have the resources needed to rid the world of polio once and for all."

Adds Rotary International President Wilfrid J. Wilkinson: "This endorsement of Rotary's polio eradication efforts by the Bill & Melinda Gates Foundation is just the catalyst and challenge Rotary members need to keep our promise to the children of the world that polio will be eradicated."

The Gates Foundation grant comes at a crucial juncture for the initiative, which urgently needs an infusion of funds to reach the eradication goal. Although the GPEI has succeeded in slashing the number of polio cases by 99 percent over the past two decades, the wild poliovirus still persists in four countries: Afghanistan, India, Nigeria and Pakistan. The polio cases represented by that final one percent are the most costly to prevent due to such factors as geographical isolation, worker fatigue, low coverage with the vaccine, armed conflict and cultural barriers.

Last month, WHO released data confirming that all four remaining polio-endemic countries are on track to achieve eradication. In particular, significant progress has been made in India and Nigeria, which together account for 85 percent of the world’s polio cases. Nigeria has reported 226 cases so far this year, compared with 958 at the same time last year. In both countries, more effective oral polio vaccines have contributed to steady progress in reducing polio cases.

WHO Director-General Dr. Margaret Chan says the Gates Foundation grant reaffirms that polio eradication is both feasible and achievable. "This investment is precisely the catalyst we need as we intensify the push to finish polio," said Chan. "We have the technical tools to do it, and we can achieve a polio-free world if the rest of our financial partners step up to meet the challenge."

Most of the initial $100 million will be spent in support of mass immunization campaigns in polio-affected countries, poliovirus surveillance activities and community education and outreach. The grant will also support an expanded research agenda on ways to halt the spread of the poliovirus. Rotary will distribute the funds through grants to WHO and UNICEF.

"The funds made possible through the Gates Foundation grant will help the Global Polio Eradication Initiative scale up its efforts to provide oral polio vaccine to children in those isolated locations where it’s most needed," says UNICEF Executive Director Ann M. Veneman. "This important contribution will improve the capacity to protect vulnerable children from this debilitating disease."

CDC Director Dr. Julie Gerberding says the collaboration between Rotary and the Gates Foundation underscores the importance of private sector involvement in major public health efforts. "As a government agency, we think it’s wonderful that our private-sector colleagues have taken a leadership role in something as important as polio eradication. Their participation is absolutely critical."

Founded in Chicago in 1905, Rotary is a worldwide organization of business and professional leaders who provide humanitarian service and help to build goodwill and peace in the world. Rotary’s global membership is approximately 1.2 million men and women who belong to more than 32,000 Rotary clubs in more than 200 countries and geographical areas.

For video and photos go to: www.thenewsmarket.com/rotaryinternational